Carrier screening for mucolipidosis type IV in the American Ashkenazi Jewish population

Am J Hum Genet. 2002 Apr;70(4):1023-7. doi: 10.1086/339519. Epub 2002 Feb 13.

Abstract

Mutations in the MCOLN1 gene cause mucolipidosis type IV (MLIV), a severely debilitating, autosomal recessive, lysosomal storage disorder. Approximately 80% of patients with MLIV are of Ashkenazi Jewish (AJ) descent, and two mutations, IVS3-2A-->G and 511del6434, account for >95% of the mutant alleles in this population. To determine the carrier frequencies of these two mutations, 2,029 anonymous, unrelated, unaffected AJ individuals from the greater New York metropolitan area were screened. A multiplex PCR method coupled with allele-specific oligonucleotide hybridization was developed, to enable large-scale screening. The frequencies of the IVS3-2A-->G and 511del6434 mutations were 0.54% and 0.25%, respectively, for a combined carrier frequency of 0.79%, or 1 in 127 individuals (95% CI 0.40%-1.17%). The addition of both AJ mutations causing this neurodegenerative disorder should be considered for prenatal carrier screening in this population.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Alleles
  • Founder Effect
  • Gene Frequency / genetics
  • Genetic Carrier Screening*
  • Genetic Testing*
  • Heterozygote*
  • Humans
  • Israel
  • Jews / genetics*
  • Membrane Proteins / genetics*
  • Molecular Sequence Data
  • Mucolipidoses / genetics*
  • Mutation / genetics*
  • New York City
  • Prenatal Diagnosis
  • TRPM Cation Channels
  • Transient Receptor Potential Channels

Substances

  • MCOLN1 protein, human
  • Membrane Proteins
  • TRPM Cation Channels
  • Transient Receptor Potential Channels

Associated data

  • GENBANK/AF287270
  • OMIM/MIM252650
  • OMIM/MIM605248